BA
AMED

Bridgewater Associates’s Amedisys AMED Stock Holding History

Bridgewater Associates’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,686
Closed -$335K – 676
2024
Q4 		$335K Sell
3,686
-9,138
-71% -$839K ﹤0.01% 618
2024
Q3 		$1.24M Sell
12,824
-14,189
-53% -$1.38M 0.01% 573
2024
Q2 		$2.48M Sell
27,013
-2,597
-9% -$241K 0.01% 494
2024
Q1 		$2.73M Sell
29,610
-5,036
-15% -$472K 0.01% 454
2023
Q4 		$3.29M Sell
34,646
-3,628
-9% -$339K 0.02% 434
2023
Q3 		$3.57M Buy
38,274
+3,179
+9% +$294K 0.02% 408
2023
Q2 		$3.21M Sell
35,095
-4,128
-11% -$339K 0.02% 387
2023
Q1 		$2.88M Sell
39,223
-980
-2% -$84.8K 0.02% 402
2022
Q4 		$3.36M Sell
40,203
-10,966
-21% -$989K 0.02% 440
2022
Q3 		$4.95M Sell
51,169
-184
-0.4% -$21.9K 0.03% 379
2022
Q2 		$5.4M Buy
51,353
+3,364
+7% +$430K 0.02% 461
2022
Q1 		$8.27M Buy
47,989
+12,438
+35% +$1.86M 0.03% 336
2021
Q4 		$5.75M Buy
35,551
+1,502
+4% +$241K 0.03% 265
2021
Q3 		$5.08M Sell
34,049
-1,225
-3% -$255K 0.03% 287
2021
Q2 		$8.64M Buy
35,274
+16,190
+85% +$4.25M 0.06% 237
2021
Q1 		$5.05M Buy
19,084
+246
+1% +$69.4K 0.04% 224
2020
Q4 		$5.53M Buy
18,838
+10,932
+138% +$2.8M 0.05% 186
2020
Q3 		$1.87M Buy
+7,906
New +$1.8M 0.02% 269

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Bridgewater Associates's AMED Position: Q1 2025 in Review

Bridgewater Associates sold out of Amedisys (AMED) in Q1 2025, closing a stake of 3,686 shares — an estimated $335K sold.

Bridgewater Associates first reported a position in AMED in Q3 2020 and held it in 18 quarters. The position peaked at $8.64M in Q2 2021. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Bridgewater Associates reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 3,686 Amedisys shares in Q1 2025, an estimated $335K.
  • Bridgewater Associates first reported a position in Amedisys in Q3 2020 and held it in 18 quarters.
  • Bridgewater Associates's Amedisys position peaked at $8.64M in Q2 2021.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.